ABT-116

ABT-116 is an orally active antagonist of transient receptor potential vanilloid type 1 (TRPV1) . ABT-116 has analgesic efficacy. ABT-116 can be used for the research of neurological disease[1].

Product Specifications

CAS Number

[1008529-42-7]

UNSPSC

12352005

Target

TRP Channel

Related Pathways

Membrane Transporter/Ion Channel; Neuronal Signaling

Field of Research

Neurological Disease

Smiles

O=C(NCC1=CC=C(C(F)(F)F)C=C1CCC(C)(C)C)NC2=CC=CC3=C2C=NN3C

Molecular Formula

C23H27F3N4O

Molecular Weight

432.48

References & Citations

[1]Niyom S, et al. Comparison of the analgesic efficacy of oral ABT-116 administration with that of transmucosal buprenorphine administration in dogs. Am J Vet Res. 2012 Apr;73 (4) :476-81.